- International counterpart to the FDA: How do other countries regulate drugs and devices?
Ruth Lopert, MD, Deputy Director, Pharmaceutical Policy & Strategy at Management Sciences for Health, and Adjunct Professor, Department of Health Policy & Management, George Washington University; former Chief Medical Officer in Australia’s Therapeutic Goods Administration (Feb 2016) - The Use of Surrogate Markers in Clinical Research
Vinay Prasad, MD, MPH – Hematologist-Oncologist, Assistant Professor of Medicine, Oregon Health Sciences University (Jan 2016) - Opioids and the FDA
Jane Ballantyne, MD, FRCA, University of Washington Professor of Education and Research, Director of UW Pain Fellowship
(Dec 2015) - Impact of the 21st Century Cures Act on FDA Medical Device Regulation
Sanket Dhruva, MD, Robert Wood Johnson Foundation Clinical Scholar, Yale University, VA Connecticut Healthcare System
(Sept 2015) - How physicians and theFDA are contributing to our addiction crisis
Andrew Kolodny, MD, Phoenix House Chief Medical Officer
(July 2015) - The Health Implications of Upcoming Trade Agreements (TPP and TTIP)
Peter Maybarduk, Director, Public Citizen’s Global Access to Medicines Program (June 2015) - How Psychiatric Drugs are Reviewed at the FDA
Erick Turner, MD, Associate professor of psychiatry at the Oregon Health and Science University, former medical officer at the FDA. (May 2015) - The Antibiotic Era
Scott Podolsky, MD, Director of the Center for the History of Medicine, Harvard, primary care internist at Massachusetts General Hospital (April 2015) - Health Policy Update: 3 New Articles on Current Issues
Aaron Kesselheim, MD, JD, MPH, Associate Professor, Harvard Medical School, currently visiting professor at Yale Law School teaching food and drug administration law (March 2015) - NPA FDA Task Force Special Webinar – AMSA Online Training: Antibiotic Resistance
ADAPT, PATH & HEAL preparation for 2015 AMSA Lobby Day with NPA FDA Taskforce members
Tejan Shah, Associate in Research, Program on Global Health and Technology Access, Duke University (Feb 2015) - Responsible Sharing of Clinical Data
Joseph Ross, MD, MHS, Yale University School of Medicine
(Dec 2014) - Anti-Infective Drug Advisory Committee Meeting
Reshma Ramachandran, MD, MPP, Candidate at Brown Medical School and Harvard Kennedy School; NPA FDA Task Force Co-Chair (Dec 2014) - Physiology is Not Fate
Rosemary Johann-Liang, MD, Pediatrician, NPA FDA Task Force Member, Rockville, MD
AccessAbility MedCare, CEO & Founder (Nov 2014) - Avoiding the antibiotic apocalypse: The role of incentives and regulation
Kevin Outterson, J.D., Boston University Health Law Program Director, Journal of Law, Medicine and Ethics Editor-in-Chief
(July 2014) - Antibiotics in animal feed: evidence of harmful effects, and what role can the FDA play in regulating this?
Michael Crupain, MD,MPH, Director of Food Safety and Sustainability Center at Consumer Reports (Feb 2014) - Expedited Approval Pathways
Dr. David Ross, MD, PhD, MBI, Associate Clinical Professor of Medicine George Washington University School of Medicine and Health Sciences (Sept 2013) - FDA Basics: History & Review Standards for Drugs and Devices
John Powers, MD FACP FIDSA, Associate Clinical Professor of Medicine George Washington University School of Medicine (August 2013)